Compounds > mefloquine

Page last updated: 2024-08-23

mefloquine and thioridazine

mefloquine has been researched along with thioridazine in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (16.67)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (50.00)	24.3611
2020's	2 (33.33)	2.80

Authors

Authors	Studies
Freiwald, S; Jiang, Y; Jones, JP; Kaspera, R; Katayama, J; Lee, CA; Smith, E; Totah, RA; Walker, GS	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Kumari, D; Perveen, S; Sharma, R; Singh, K	1
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF	1
Bergqvist, Y; Breyer, S; Burgmann, H; Feistauer, S; Feucht, M; Graninger, W; Hellgren, U; Uhl, F; Winkler, S	1
Bhatia, M; Brown, ED; Collins, TJ; Fiebig-Comyn, A; Fischer-Russell, D; Foley, R; Giacomelli, AO; Graham, M; Hassell, JA; Laronde, S; Leber, B; Lee, JB; Lee, JH; Levadoux-Martin, M; Malig, M; McNicol, JD; Risueño, RM; Russell, J; Sachlos, E; Shapovalova, Z; Trus, MR; Xenocostas, A	1

Reviews

3 review(s) available for mefloquine and thioridazine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Tuberculosis drug discovery: Progression and future interventions in the wake of emerging resistance. European journal of medicinal chemistry, 2022, Feb-05, Volume: 229 Topics: Antitubercular Agents; Diarylquinolines; Drug Therapy, Combination; Ethambutol; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Pyrazinamide; Rifampin	2022
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators. European journal of medicinal chemistry, 2022, Jul-05, Volume: 237 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells	2022

Other Studies

3 other study(ies) available for mefloquine and thioridazine

Article	Year
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:5 Topics: Amiodarone; Astemizole; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Danazol; Drug Discovery; Drug Interactions; Enzyme Inhibitors; Humans; Hydroxylation; In Vitro Techniques; Methylation; Microsomes, Liver; Models, Biological; Molecular Structure; Substrate Specificity; Tandem Mass Spectrometry; Terfenadine	2012
[Mefloquine and sulfadoxine/pyrimethamine overdose in malaria tropica]. Wiener klinische Wochenschrift, 1993, Volume: 105, Issue:2 Topics: Adult; Diazepam; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Haloperidol; Humans; Malaria, Falciparum; Male; Mefloquine; Psychoses, Substance-Induced; Pyrimethamine; Sulfadoxine; Thioridazine	1993
Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells. Cell, 2012, Jun-08, Volume: 149, Issue:6 Topics: Animals; Antineoplastic Agents; Cytarabine; Dopamine Antagonists; Drug Screening Assays, Antitumor; Humans; Leukemia, Myeloid, Acute; Mefloquine; Mice; Neoplastic Stem Cells; Pluripotent Stem Cells; Pyrans; Thioridazine	2012